Effects of Switching From a Dipeptidyl Peptidase-4 Inhibitor to Luseogliflozin on Nocturnal Blood Pressure in Patients With Type 2 Diabetes: Protocol for a Multicentre, Prospective, Randomised, Open-Label, Blinded Endpoint Parallel-Group Comparison Study

BMJ Open - United Kingdom
doi 10.1136/bmjopen-2019-034883

Related search